NCT00133185View on ClinicalTrials.gov

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Hypertension
Interventions
DRUG

telmisartan 40 mg/hydrochlorothiazide 12.5 mg

DRUG

losartan 50 mg/hydrochlorothiazide 12.5 mg

Trial Locations (1)

104

Machay Memorial Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY